The minimum required interval between hydrogel spacer injection and treatment planning for stereotactic body radiotherapy for prostate cancer.

As no studies have investigated the short-term characteristics (<3 days) of a hydrogel spacer, the current study evaluated the short-term characteristics of a spacer from the time of injection during stereotactic body radiation therapy (SBRT) for prostate cancer.